JP2017222671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017222671A5
JP2017222671A5 JP2017130471A JP2017130471A JP2017222671A5 JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5 JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017130471 A JP2017130471 A JP 2017130471A JP 2017222671 A5 JP2017222671 A5 JP 2017222671A5
Authority
JP
Japan
Prior art keywords
compound
conjugate
protein
immunogenic carrier
ovalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017130471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017222671A (ja
JP6423490B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017222671A publication Critical patent/JP2017222671A/ja
Publication of JP2017222671A5 publication Critical patent/JP2017222671A5/ja
Application granted granted Critical
Publication of JP6423490B2 publication Critical patent/JP6423490B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017130471A 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン Active JP6423490B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691454P 2012-08-21 2012-08-21
US61/691,454 2012-08-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015528568A Division JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018196525A Division JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Publications (3)

Publication Number Publication Date
JP2017222671A JP2017222671A (ja) 2017-12-21
JP2017222671A5 true JP2017222671A5 (enExample) 2018-02-22
JP6423490B2 JP6423490B2 (ja) 2018-11-14

Family

ID=49081007

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン
JP2017130471A Active JP6423490B2 (ja) 2012-08-21 2017-07-03 オランザピン(Olanzipine)のハプテン
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015528568A Active JP6171014B2 (ja) 2012-08-21 2013-08-20 オランザピン(Olanzipine)のハプテン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018196525A Active JP6763000B2 (ja) 2012-08-21 2018-10-18 オランザピン(Olanzipine)のハプテン

Country Status (11)

Country Link
US (1) US9303041B2 (enExample)
EP (2) EP3492473B1 (enExample)
JP (3) JP6171014B2 (enExample)
CN (1) CN104854110B (enExample)
AU (1) AU2013306018B2 (enExample)
CA (1) CA2882454C (enExample)
ES (2) ES3043017T3 (enExample)
PL (1) PL2888269T3 (enExample)
PT (1) PT2888269T (enExample)
TR (1) TR201816378T4 (enExample)
WO (1) WO2014031587A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104755093B (zh) 2012-08-21 2018-11-16 詹森药业有限公司 奥氮平半抗原的抗体及其用途
PT3663317T (pt) 2012-08-21 2023-01-23 Janssen Pharmaceutica Nv Anticorpos para haptenos de quetiapina e sua utilização
EP3492473B1 (en) * 2012-08-21 2025-07-30 Janssen Pharmaceutica NV Haptens of olanzapine
CN104755928B (zh) 2012-08-21 2017-05-10 詹森药业有限公司 奥氮平的抗体及其用途
ES2978909T3 (es) 2012-08-21 2024-09-23 Janssen Pharmaceutica Nv Anticuerpos contra haptenos de aripiprazol y uso de los mismos
WO2014031668A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to quetiapine and use thereof
TR201816416T4 (tr) 2012-08-21 2018-11-21 Janssen Pharmaceutica Nv Risperidona yönelik antikorlar ve bunların kullanımı.
JP6374387B2 (ja) 2012-08-21 2018-08-15 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンハプテンへの抗体及びその使用
ES2822914T3 (es) 2012-08-21 2021-05-05 Janssen Pharmaceutica Nv Haptenos de aripiprazol y su uso en inmunoensayos
ES2762105T3 (es) 2012-08-21 2020-05-22 Janssen Pharmaceutica Nv Anticuerpos para aripiprazol y uso de los mismos
AU2013305965B2 (en) 2012-08-21 2017-08-24 Saladax Biomedical Inc. Antibodies to paliperidone and use thereof
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
CN108431040B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 利培酮的抗体及其用途
AU2016370853A1 (en) 2015-12-17 2018-06-07 Saladax Biomedical Inc. Antibodies to quetiapine and use thereof
CN110950808A (zh) * 2019-10-30 2020-04-03 杭州博拓生物科技股份有限公司 一种氯氮平人工抗原及其制备方法
CN110938082A (zh) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 一种奥氮平人工抗原及其制备方法
AU2021406283A1 (en) * 2020-12-22 2023-06-22 Intervet International B.V. Conjugated zearalenone to protect against mycotoxicosis
CN114685527B (zh) * 2020-12-25 2024-03-05 长沙博源医疗科技有限公司 一种奥氮平衍生物、免疫原、抗奥氮平特异性抗体及其制备方法与应用
CN114685477B (zh) * 2020-12-25 2023-11-17 长沙博源医疗科技有限公司 一种利奈唑胺衍生物、免疫原、抗利奈唑胺特异性抗体及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022780A (en) 1973-03-06 1977-05-10 Imperial Chemical Industries Limited Process for the manufacture of indole derivatives
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
EP0582368B1 (en) * 1992-05-29 2001-01-24 Eli Lilly And Company Limited Thienobenzodiazepine derivatives for treatment of CNS disorders
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
EP0576095B1 (en) * 1992-06-26 1999-01-27 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays with labeled thyronine hapten analogues
US5395933A (en) * 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
ATE380818T1 (de) * 2002-03-28 2007-12-15 Lilly Co Eli Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
ES2285227T3 (es) * 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
EP1664007B1 (en) 2003-09-23 2009-12-23 Fermion Oy Preparation of quetiapine
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
KR20070053214A (ko) * 2004-08-26 2007-05-23 니콜라스 피라말 인디아 리미티드 신규 생분해성 링커를 함유하는 프로드럭
MX2010003259A (es) 2007-09-27 2010-04-12 Novartis Ag Ensayo de monitoreo de farmacos.
US20100069356A1 (en) 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010043893A1 (en) 2008-10-14 2010-04-22 Astrazeneca Ab Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
CA2785846C (en) 2009-12-31 2015-07-07 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
SI2544536T1 (sl) 2010-03-11 2019-03-29 Kempharm, Inc. Maščobno kislinski konjugati kvetiapina proces za njih izdelavo in uporabo
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
WO2013088255A1 (en) * 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
EP3492473B1 (en) * 2012-08-21 2025-07-30 Janssen Pharmaceutica NV Haptens of olanzapine

Similar Documents

Publication Publication Date Title
JP2017222671A5 (enExample)
JP2015532645A5 (enExample)
JP2015527363A5 (enExample)
JP2018184433A5 (enExample)
JP2015181191A5 (enExample)
JP2018536572A5 (enExample)
RU2013133802A (ru) Стабильные и растворимые антитела, ингибирующие vegf
JP2019524645A5 (enExample)
JP2011511933A5 (enExample)
JP2016535744A5 (enExample)
JP2009120624A5 (enExample)
CN109843873A (zh) 炔代杂环化合物、其制备方法及其在医药学上的应用
WO2018102315A8 (en) Polymorphs of sepiapterin and salts thereof
JP2013539454A5 (enExample)
JP2012001634A5 (enExample)
RU2019110152A (ru) Лекарственные средства на основе лантионинсинтетаза c-подобного белка 2
JP2015523910A5 (enExample)
JP2014521346A5 (enExample)
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
CO2017000010A2 (es) Proceso para la preparacion de ácidos 3-hidroxipicolínicos
CN112262136A (zh) 一种吡咯并氨基哒嗪酮化合物的制备方法及其中间体
JP2012515709A5 (enExample)
RU2016107486A (ru) Способ получения рифаксимина к
JP2013503145A5 (enExample)